The antimicrobial cathelicidin peptide hlF(1-11) attenuates alveolar macrophage pyroptosis induced by Acinetobacter baumannii in vivo

Experimental Cell Research

Volumn 364, Issue 1, 2018, Pages 95-103

  Dai, Minhui ^a   Pan, Pinhua ^a   Li, Haitao ^a   Liu, Shuai ^a   Zhang, Lemeng ^b   Song, Chao ^a   Li, Yi ^a   Li, Qian ^a   Mao, Zhi ^a   Long, Yuan ^a   Su, Xiaoli ^a   Hu, Chengping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

Acinetobacter baumannii; Caspase 1; hLF(1 11); Pyroptosis

Indexed keywords

AMIKACIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE HLF; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; INFLAMMASOME; LACTOFERRIN; LACTOFERRIN (1-11), HUMAN; PEPTIDE FRAGMENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PYROPTOSIS; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; DRUG EFFECT; HUMAN; MICROBIOLOGY; PATHOLOGY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; INFLAMMASOMES; LACTOFERRIN; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; PYROPTOSIS;

EID: 85041561820     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2018.01.035     Document Type: Article

References (52)

1. Bergogne-Berezin, E., Towner, K.J., Acinetobacter spp. As nosocomial pathogens: Microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9 (1996), 148–165.
2. Dijkshoorn, L., Nemec, A., Seifert, H., An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5 (2007), 939–951.
3. Antunes, L.C.S., Visca, P., Towner, K.J., Acinetobacter baumannii: evolution of a global pathogen. Pathog. Dis. 71 (2014), 292–301.
4. Pogue, J.M., Mann, T., Barber, K.E., Kaye, K.S., Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management. Expert Rev. Anti-Infect. Ther. 11 (2013), 383–393.
5. Zheng, Y.L., Wan, Y.F., Zhou, L.Y., Ye, M.L., Liu, S., Xu, C.Q., He, Y.Q., Chen, J.H., Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia. Am. J. Infect. Control 41 (2013), e59–e63.
6. Lemos, E.V., de la Hoz, F.P., Einarson, T.R., McGhan, W.F., Quevedo, E., Castaneda, C., Kawai, K., Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin. Microbiol. Infect. 20 (2014), 416–423.
7. Dick, A.W., Perencevich, E.N., Pogorzelska-Maziarz, M., Zwanziger, J., Larson, E.L., Stone, P.W., A decade of investment in infection prevention: a cost-effectiveness analysis. Am. J. Infect. Control 43 (2015), 4–9.
8. Nair, G.B., Niederman, M.S., Ventilator-associated pneumonia: present understanding and ongoing debates. Intensive Care Med. 41 (2015), 34–48.
9. Richards, M.J., Edwards, J.R., Culver, D.H., Gaynes, R.P., Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med. 27 (1999), 887–892.
10. Gaddy, J.A., Arivett, B.A., McConnell, M.J., Lopez-Rojas, R., Pachon, J., Actis, L.A., Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice. Infect. Immun. 80 (2012), 1015–1024.
11. Qiu, H., KuoLee, R., Harris, G., Van Rooijen, N., Patel, G.B., Chen, W., Role of macrophages in early host resistance to respiratory Acinetobacter baumannii infection. PLOS One, 7, 2012, e40019.
12. Man, S.M., Karki, R., Kanneganti, T.D., Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol. Rev. 277 (2017), 61–75.
13. Gordon, S.B., Read, R.C., Macrophage defences against respiratory tract infections. Br. Med. Bull. 61 (2002), 45–61.
14. Steele, C., Marrero, L., Swain, S., Harmsen, A.G., Zheng, M., Brown, G.D., Gordon, S., Shellito, J.E., Kolls, J.K., Alveolar macrophage-mediated killing of Pneumocystis carinii f. Sp. Muris involves molecular recognition by the Dectin-1 beta-glucan receptor. J. Exp. Med. 198 (2003), 1677–1688.
15. He, Y., Amer, A.O., Microbial modulation of host apoptosis and pyroptosis. Front Cell Infect. Microbiol., 4, 2014, 83.
16. Jorgensen, I., Miao, E.A., Pyroptotic cell death defends against intracellular pathogens. Immunol. Rev. 265 (2015), 130–142.
17. Cohen, T.S., Prince, A.S., Activation of inflammasome signaling mediates pathology of acute P. Aeruginosa pneumonia. J. Clin. Invest. 123 (2013), 1630–1637.
18. Faure, E., Mear, J.B., Faure, K., Normand, S., Couturier-Maillard, A., Grandjean, T., Balloy, V., Ryffel, B., Dessein, R., Chignard, M., Uyttenhove, C., Guery, B., Gosset, P., Chamaillard, M., Kipnis, E., Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome. Am. J. Respir. Crit. Care Med. 189 (2014), 799–811.
19. Theisen, E., Sauer, J.D., Listeria monocytogenes-Induced cell death inhibits the generation of cell-mediated immunity. Infect. Immun., 85, 2017.
20. Ong, Z.Y., Wiradharma, N., Yang, Y.Y., Strategies employed in the design and optimization of synthetic antimicrobial peptide amphiphiles with enhanced therapeutic potentials. Adv. Drug Deliv. Rev. 78 (2014), 28–45.
21. Deng, T., Ge, H., He, H., Liu, Y., Zhai, C., Feng, L., Yi, L., The heterologous expression strategies of antimicrobial peptides in microbial systems. Protein Expr. Purif. 140 (2017), 52–59.
22. van der Does, A.M., Bogaards, S.J., Jonk, L., Wulferink, M., Velders, M.P., Nibbering, P.H., The human lactoferrin-derived peptide hLF1-11 primes monocytes for an enhanced TLR-mediated immune response. Biometals 23 (2010), 493–505.
23. Gifford, J.L., Hunter, H.N., Vogel, H.J., Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell. Mol. Life Sci. 62 (2005), 2588–2598.
24. Nibbering, P.H., Ravensbergen, E., Welling, M.M., van Berkel, L.A., van Berkel, P.H., Pauwels, E.K., Nuijens, J.H., Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infect. Immun. 69 (2001), 1469–1476.
25. Brouwer, C.P., Welling, M.M., Various routes of administration of (99m)Tc-labeled synthetic lactoferrin antimicrobial peptide hLF 1-11 enables monitoring and effective killing of multidrug-resistant Staphylococcus aureus infections in mice. Peptides 29 (2008), 1109–1117.
26. Dijkshoorn, L., Brouwer, C., Bogaards, S., Nemec, A., van den Broek, P.J., Nibbering, P.H., The synthetic n-terminal peptide of human lactoferin, hLF(1-11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 48 (2004), 4919–4921.
27. Dijkshoorn, L., Nemec, A., Seifert, H., An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5 (2007), 939–951.
28. van der Velden, W.J.F.M., van Iersel, T.M.P., Blijlevens, N.M.A., Donnelly, J.P., Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11). BMC Med., 7, 2009.
29. van der Does, A.M., Bogaards, S.J., Ravensbergen, B., Beekhuizen, H., van Dissel, J.T., Nibbering, P.H., Antimicrobial peptide hLF1-11 directs granulocyte-macrophage colony-stimulating factor-driven monocyte differentiation toward macrophages with enhanced recognition and clearance of pathogens. Antimicrob. Agents Chemother. 54 (2010), 811–816.
30. Fields, G.B., Noble, R.L., Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 35 (1990), 161–214.
31. Collins, J.M., Leadbeater, N.E., Microwave energy: a versatile tool for the biosciences. Org. Biomol. Chem. 5 (2007), 1141–1150.
32. Tan, H., Li, M., Wan, Z., Pan, P., Su, X., Hu, C., Sequence type 191 of clonal complex 92 was a dominant carbapenem-resistant acinetobacter baumannii that causes nosocomial pneumonia in intensive care units in a teaching hospital in central china. Clin. Lab. 62 (2016), 1421–1426.
33. Parra, M.R., Jimenez, M.M., Sanchez, E.V., Ayerbe, A.R., Gutierrez, V.A., Pachon, I.M., Diaz, C., Perez, D.P.J., Lopez, C.L., Pachon, J., Smani, Y., Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models. Antimicrob. Agents Chemother. 60 (2016), 4464–4470.
34. Fan, J., Marshall, J.C., Jimenez, M., Shek, P.N., Zagorski, J., Rotstein, O.D., Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: Role in pulmonary inflammation following lipopolysaccharide. J. Immunol. 161 (1998), 440–447.
35. McGuigan, R.M., Mullenix, P., Norlund, L.L., Ward, D., Walts, M., Azarow, K., Acute lung injury using oleic acid in the laboratory rat: establishment of a working model and evidence against free radicals in the acute phase. Curr. Surg. 60 (2003), 412–417.
36. Wu, D., Pan, P., Su, X., Zhang, L., Qin, Q., Tan, H., Huang, L., Li, Y., Interferon regulatory factor-1 mediates alveolar macrophage pyroptosis during LPS-Induced acute lung injury in mice. Shock 46 (2016), 329–338.
37. Fink, S.L., Bergsbaken, T., Cookson, B.T., Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms. Proc. Natl. Acad. Sci. USA 105 (2008), 4312–4317.
38. Huang, P., Shie, S., Ye, J., Lin, S., Liu, T., Wu, T., Wu, T., Chuang, S., Cheng, M., Hsieh, Y., Huang, C., Acquisition and clearance of multidrug resistant Acinetobacter baumannii on healthy young adults concurrently burned in a dust explosion in Taiwan: the implication for antimicrobial stewardship. BMC Infect. Dis., 17, 2017.
39. Alejandro Marquez-Ortiz, R., Haggerty, L., Olarte, N., Duarte, C., Garza-Ramos, U., Silva-Sanchez, J., Castro, B.E., Sim, E.M., Beltran, M., Moncada, M.V., Valderrama, A., Castellanos, J.E., Charles, I.G., Vanegas, N., Escobar-Perez, J., Petty, N.K., Genomic epidemiology of NDM-1-Encoding plasmids in latin american clinical isolates reveals insights into the evolution of multidrug resistance. Genome Biol. Evol. 9 (2017), 1725–1741.
40. Salehi, M.D., Ferdosi-Shahandashti, E., Yahyapour, Y., Khafri, S., Pournajaf, A., Rajabnia, R., Integron-Mediated Antibiotic Resistance in Acinetobacter baumannii Isolated from Intensive Care Unit Patients, Babol, North of Iran. Biomed. Res. Int., 2017.
41. Tanguy, M., Kouatchet, A., Tanguy, B., Pichard, E., Fanello, S., Joly-Guillou, M., Management of an Acinetobacter baumannii outbreak in an intensive care unit. Med. Mal. Infect., 2017.
42. Andrade, W.A., Zamboni, D.S., Inflammasome-dependent mechanisms involved in sensing and restriction of bacterial replication. Curr. Issues Mol. Biol. 25 (2017), 99–132.
43. Chen, Y.L., Xu, G., Liang, X., Wei, J., Luo, J., Chen, G.N., Yan, X.D., Wen, X.P., Zhong, M., Lv, X., Inhibition of hepatic cells pyroptosis attenuates CLP-induced acute liver injury. Am. J. Transl. Res. 8 (2016), 5685–5695.
44. Shi, J., Gao, W., Shao, F., Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem. Sci. 42 (2017), 245–254.
45. Taabazuing, C.Y., Okondo, M.C., Bachovchin, D.A., Pyroptosis and apoptosis pathways engage in bidirectional crosstalk in monocytes and macrophages. Cell Chem. Biol. 24 (2017), 507–514.
46. Lien, E., Sellati, T.J., Yoshimura, A., Flo, T.H., Rawadi, G., Finberg, R.W., Carroll, J.D., Espevik, T., Ingalls, R.R., Radolf, J.D., Golenbock, D.T., Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274 (1999), 33419–33425.
47. Kim, C.H., Jeong, Y.J., Lee, J., Jeon, S.J., Park, S.R., Kang, M.J., Park, J.H., Park, J.H., Essential role of toll-like receptor 4 in Acinetobacter baumannii-induced immune responses in immune cells. Microb. Pathog. 54 (2013), 20–25.
48. Jorgensen, I., Rayamajhi, M., Miao, E.A., Programmed cell death as a defence against infection. Nat. Rev. Immunol. 17 (2017), 151–164.
49. Jha, C., Ghosh, S., Gautam, V., Malhotra, P., Ray, P., In vitro study of virulence potential of Acinetobacter baumannii outer membrane vesicles. Microb. Pathog. 111 (2017), 218–224.
50. van der Does, A.M., Joosten, S.A., Vroomans, E., Bogaards, S.J., van Meijgaarden, K.E., Ottenhoff, T.H., van Dissel, J.T., Nibbering, P.H., The antimicrobial peptide hLF1-11 drives monocyte-dendritic cell differentiation toward dendritic cells that promote antifungal responses and enhance Th17 polarization. J. Innate Immun. 4 (2012), 284–292.
51. Dijkshoorn, L., Brouwer, C.P., Bogaards, S.J., Nemec, A., van den Broek, P.J., Nibbering, P.H., The synthetic N-terminal peptide of human lactoferrin, hLF(1-11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 48 (2004), 4919–4921.
52. Lazaro-Diez, M., Chapartegui-Gonzalez, I., Redondo-Salvo, S., Leigh, C., Merino, D., Segundo, D.S., Navas, J., Icardo, J.M., Acosta, F., Ocampo-Sosa, A., Martinez-Martinez, L., Ramos-Vivas, J., Human neutrophils phagocytose and kill Acinetobacter baumannii and a. Pittii. Sci. Rep., 7, 2017, 4571.